( NASDAQ-NMS:CHUX )

News from Bernstein Liebhard LLP A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 15, 2017, 11:27 ET Nexium Lawsuits, Other Proton Pump Inhibitor Claims Alleging Kidney Failure, Chronic Kidney Disease, and Other Renal Complications Centralized in New Jersey Federal Court, Bernstein Liebhard LLP Reports

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has created a consolidated docket for all federally-filed proton pump inhibitor lawsuits...


Aug 14, 2017, 12:53 ET Federal Xarelto Lawsuits Move Forward, as Third Bellwether Case Heads to Trial in Mississippi, Bernstein Liebhard LLP Reports

The federal litigation established for Xarelto lawsuits in the U.S. District Court, Eastern District of Louisiana, continues to move forward....


Aug 09, 2017, 11:55 ET Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against Applied Optoelectronics, Inc.

Bernstein Liebhard LLP announces that a securities class action has been filed in the United States District Court for the Southern District of...


Aug 08, 2017, 14:00 ET Bernstein Liebhard LLP Announces Investigation Into The Proposed Sale Of NCI, Inc.

Bernstein Liebhard LLP is investigating whether the Board of Directors of NCI, Inc. ("NCI" or the "Company") (NASDAQ: NCIT) breached its fiduciary...


Aug 07, 2017, 12:19 ET Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania, As Sixth Trial Kicks Off in Philadelphia, Bernstein Liebhard LLP Reports

A Pennsylvania jury is now hearing evidence in the state's sixth trial involving allegedly defective transvaginal mesh devices marketed by Johnson...


Aug 03, 2017, 12:01 ET Actemra Lawsuit Evaluations Offered by Bernstein Liebhard LLP Following Report Linking Novel RA Medication to Serious, Unlabeled Side Effects, Including Heart Attacks, Heart Failure, Stroke, Lung Disease, Pancreatitis and Death

The nationwide law firm of Bernstein Liebhard LLP is evaluating potential Actemra lawsuit filings on behalf of individuals who suffered serious...


Jul 31, 2017, 12:02 ET Talcum Powder Lawsuit News: Plaintiff's Toxicology Expert Testifies in First California Ovarian Cancer Trial, Bernstein Liebhard LLP Reports

California's first trial involving talcum powder and ovarian cancer is now underway in Los Angeles Superior Court. During opening statements...


Jul 24, 2017, 11:33 ET Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Note Growing Gynecomastia Litigation, As Pennsylvania Cases Exceed 5,500

The litigation involving Risperdal and gynecomastia continues to grow, with more than 5,500 cases now pending in the mass tort program currently...


Jul 17, 2017, 12:36 ET Xarelto Lawsuit News: Blood Thinner Implicated in 15,000+ Adverse Event Reports Last Year, Bernstein Liebhard LLP Reports

Xarelto lawsuits continue to mount in courts around the U.S., as do reports of life-threatening internal bleeding and other serious complications...


Jul 13, 2017, 12:41 ET Onglyza Lawsuit Evaluations Offered by Bernstein Liebhard LLP In Response to FDA Warning on Saxagliptin and Heart Failure

The nationwide law firm of Bernstein Liebhard LLP is offering Onglyza lawsuit evaluations to individuals who were diagnosed with heart failure or...


Jul 10, 2017, 11:54 ET Johnson & Johnson Talcum Powder Lawsuit Heads to Trial in California, Bernstein Liebhard LLP Reports

The first of more than 300 ovarian cancer lawsuits involving Johnson & Johnson's talcum powder products will head to trial today in Los Angeles...


Jul 03, 2017, 11:56 ET Stryker Hip Lawsuits Move Forward in New Jersey, As Court Overseeing LFIT V40 Femoral Head Claims Issues New Orders, Bernstein Liebhard LLP Reports

Product liability claims involving Stryker's recalled LFIT Anatomic CoCr V40 Femoral Heads are moving forward in the multicounty litigation...


Jun 26, 2017, 12:02 ET Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania Mass Tort Program, As Court Schedules July Meeting, Bernstein Liebhard LLP Reports

Transvaginal mesh lawsuits filed against Johnson & Johnson and its Ethicon, Inc. subsidiary continue to move forward in a mass tort litigation...


Jun 23, 2017, 13:44 ET Parties to Pennsylvania Risperdal Gynecomastia Lawsuits Set to Meet Next Month to Discuss Status of Mass Tort Litigation, Bernstein Liebhard LLP Reports

Thousands of Risperdal lawsuits involving the antipsychotic medication's alleged potential to cause gynecomastia (male breast growth) continue to...


Jun 19, 2017, 12:23 ET $3.3 Million Ethicon Transvaginal Mesh Verdict May be Headed to U.S. Supreme Court, Bernstein Liebhard LLP Reports

Johnson & Johnson's Ethicon, Inc. subsidiary has asked the U.S. Supreme Court to review a $3.3 million verdict awarded in a transvaginal mesh...


Jun 12, 2017, 11:56 ET Talcum Powder Lawsuit News: Jury Hears Opening Statements in Missouri's Sixth Ovarian Cancer Trial, Bernstein Liebhard LLP Reports

Missouri's sixth trial involving Johnson & Johnson's talcum powder products and their alleged association with ovarian cancer is now underway...


Jun 05, 2017, 14:07 ET Stryker Hip Recall News: New Jersey Supreme Court Centralizes Product Liability Lawsuits Involving L-FIT V40 Femoral Heads in Bergen County Superior Court, Bernstein Liebhard LLP Reports

The New Jersey Supreme Court has agreed to grant Multicounty Litigation designation to all Stryker hip replacement lawsuits involving allegedly...


May 30, 2017, 12:09 ET Transvaginal Mesh Lawsuit Plaintiff Awarded $2.1 Million, As Johnson & Johnson Loses Fourth Pennsylvania Trial, Bernstein Liebhard LLP Reports

A Pennsylvania jury has awarded $2.1 million to a woman who suffered serious complications after Ethicon, Inc.'s Gynecare Prolift mesh deteriorated...


May 24, 2017, 13:30 ET Xarelto Lawsuit Filings Exceed 18,000, as Second Bellwether Trial Set to Get Underway, Bernstein Liebhard LLP Reports

Xarelto patients who suffered internal bleeding and other life-threatening complications allegedly related to use of the medication continue to...


May 22, 2017, 12:02 ET Risperdal Lawsuits Continue to Plague Johnson & Johnson, With More Than 16,000 Filings Nationwide, Bernstein Liebhard LLP Reports

Johnson & Johnson and its Janssen Pharmaceuticals subsidiary continue to face legal claims over gynecomastia and other side effects allegedly...


May 17, 2017, 11:08 ET Talcum Powder Wrongful Death Lawsuits Consolidated for Upcoming Ovarian Cancer Trial in Missouri, Bernstein Liebhard LLP Reports

The Missouri state court overseeing hundreds of talcum powder ovarian cancer claims has consolidated three wrongful death cases for a trial...


May 15, 2017, 12:27 ET Invokana Lawsuits Move Forward, With Issuance of Two New Orders in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports

The federal multidistrict litigation overseeing hundreds of products liability lawsuits involving Invokana and Invokamet are moving forward in the...


May 10, 2017, 12:10 ET Pennsylvania Transvaginal Mesh Lawsuit Plaintiffs Hope to Extend Winning Streak, As Fourth Ethicon Trial Opens in Philadelphia, Bernstein Liebhard LLP Reports

A jury is now hearing evidence in Pennsylvania's fourth trial involving allegedly defective transvaginal mesh implants manufactured by Johnson...


May 08, 2017, 12:32 ET Onglyza Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Growing Heart Failure Litigation Involving Type 2 Diabetes Medications, Onglyza and Kombiglyze XR

The nationwide law firm of Bernstein Liebhard LLP is monitoring the growing litigation involving Onglyza and Kombiglyze XR, Type 2 diabetes...


May 05, 2017, 12:14 ET Johnson & Johnson Loses Another Talcum Powder Lawsuit, As Missouri Jury Awards More Than $110 Million to Ovarian Cancer Victim, Bernstein Liebhard LLP Reports

A Missouri jury has ordered Johnson & Johnson and Imery's Talc to pay $110.5 million to a Virginia woman who developed ovarian cancer following...